| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |